However, sequence analysis revealed smaller secondary clones of expanded CD4+ T cells in most tumors (∼10% of the CDR3 sequences) and the outgrowth of one of these during ex vivo culture indicates the tumor potential of sub-dominant CD4+ clones. Here, CD4 is linked to neoplasm.